相关实验视频
Updated: Jul 1, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
组织等离子原激活剂在急性心脏骤停中的作用
Indira Acharya1, Scott R DeBoer2,3, Christopher J Haas2,3
1Medstar Health Internal Medicine Residency Program, Baltimore, MD, USA.
Journal of community hospital internal medicine perspectives
|March 14, 2024
概括
组织等离子素激活剂 (tPA) 用于心脏骤停,但存在内出血的风险. 这一案例突出了患者接受tPA治疗耐心性心脏骤停的罕见并发症.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 组织等离子素激活剂 (tPA) 是一种经验性治疗,用于疑似肺栓塞或心肌梗塞的耐药性医院外心脏骤停 (OHCA).
- 内出血 (ICH) 是tPA的罕见但严重的并发症,与增加的发病率和死亡率有关.
- 与tPA相关的ICH的危险因素包括先前的内出血,抗凝剂使用,低体重和严重高血压.
研究的目的:
- 在患有耐心性心脏骤停的患者中,报告tPA给药后发生的内出血病例.
- 讨论在心脏骤停的背景下管理tPA治疗的挑战,以及立即神经成像的不切实际性.
主要方法:
- 一个66岁的病人的病例报告呈现了耐心性心脏骤停.
- 对疑似肺栓塞和复发性无脉动电活动 (PEA) 进行tPA的使用.
- 随后诊断出下大脑下和心室内出血.
主要成果:
- 患者接受了tPA治疗耐心性心脏骤停,恢复自发循环 (ROSC).
- 在tPA后,患者被发现患有副arachnoid出血 (SAH) 和心室内出血 (IVH).
- 这一案例说明了与心脏骤停患者的tPA相关的罕见但严重的不良事件.
结论:
- 在耐心性心脏骤停中服用tPA会带来显著内出血的风险.
- 在心脏骤停患者中诊断和管理tPA诱导的ICH存在独特的临床挑战.
- 需要进一步的研究来完善在OHCA中使用tPA的风险分层和管理策略.
相关概念视频
Clot Retraction and Fibrinolysis
5.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.8K
Formation of the Platelet Plug
6.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
145
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
145
Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Introduction to Hemostasis
7.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.6K

